ZITHROMAX® TABLET, SUSPENSION How Supplied/Storage and Handling

(azithromycin dihydrate TABLET, SUSPENSION)

16 HOW SUPPLIED/STORAGE AND HANDLING

ZITHROMAX is supplied in the following strengths and package configurations:

Tablet strengthTablet Color/ShapeTablet MarkingsPackage SizeNDC Code

250 mg
(containing azithromycin dihydrate equivalent to 250 mg of azithromycin)

Pink modified capsular shaped, engraved, film-coated

Engraved with "PFIZER" on one side and "306" on the other

Bottles of 30

NDC 0069-3060-30

Boxes of 3 (Z-PAKS of 6)

NDC 0069-3060-75

Unit Dose package of 50

NDC 0069-3060-86

Engraved with "Pfizer" on one side and "ZTM 250" on the other

Bottles of 30

NDC 0069-4061-01

Boxes of 3 (Z-PAKS of 6)

NDC 0069-4061-75

Unit Dose package of 50

NDC 0069-4061-89

500 mg
(containing azithromycin dihydrate equivalent to 500 mg of azithromycin)

Pink modified capsular shaped, engraved, film coated

Engraved with "Pfizer" on one side and "ZTM500" on the other

Bottles of 30

NDC 0069-3070-30

Boxes of 3 (TRI-PAKS™ of 3 tablets)

NDC 0069-3070-75

ZITHROMAX tablets should be stored between 15° to 30°C (59° to 86°F).

ZITHROMAX for oral suspension after constitution contains a flavored suspension. ZITHROMAX for oral suspension is supplied to provide 100 mg/5 mL or 200 mg/5 mL suspension in bottles as follows:

Azithromycin contents per bottleNDC

300 mg

0069-3110-19

600 mg

0069-3120-19

900 mg

0069-3130-19

1200 mg

0069-3140-19

[see Dosage and Administration (2)] for constitution instructions with each bottle type.

Storage: Store dry powder below 30°C (86°F). Store constituted suspension between 5° to 30°C (41° to 86°F) and discard when full dosing is completed.

Find ZITHROMAX® TABLET, SUSPENSION medical information:

Find ZITHROMAX® TABLET, SUSPENSION medical information:

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

ZITHROMAX® TABLET, SUSPENSION Quick Finder

Prescribing Information
Download Prescribing Information

Health Professional Information

How Supplied/Storage and Handling

16 HOW SUPPLIED/STORAGE AND HANDLING

ZITHROMAX is supplied in the following strengths and package configurations:

Tablet strengthTablet Color/ShapeTablet MarkingsPackage SizeNDC Code

250 mg
(containing azithromycin dihydrate equivalent to 250 mg of azithromycin)

Pink modified capsular shaped, engraved, film-coated

Engraved with "PFIZER" on one side and "306" on the other

Bottles of 30

NDC 0069-3060-30

Boxes of 3 (Z-PAKS of 6)

NDC 0069-3060-75

Unit Dose package of 50

NDC 0069-3060-86

Engraved with "Pfizer" on one side and "ZTM 250" on the other

Bottles of 30

NDC 0069-4061-01

Boxes of 3 (Z-PAKS of 6)

NDC 0069-4061-75

Unit Dose package of 50

NDC 0069-4061-89

500 mg
(containing azithromycin dihydrate equivalent to 500 mg of azithromycin)

Pink modified capsular shaped, engraved, film coated

Engraved with "Pfizer" on one side and "ZTM500" on the other

Bottles of 30

NDC 0069-3070-30

Boxes of 3 (TRI-PAKS™ of 3 tablets)

NDC 0069-3070-75

ZITHROMAX tablets should be stored between 15° to 30°C (59° to 86°F).

ZITHROMAX for oral suspension after constitution contains a flavored suspension. ZITHROMAX for oral suspension is supplied to provide 100 mg/5 mL or 200 mg/5 mL suspension in bottles as follows:

Azithromycin contents per bottleNDC

300 mg

0069-3110-19

600 mg

0069-3120-19

900 mg

0069-3130-19

1200 mg

0069-3140-19

[see Dosage and Administration (2)] for constitution instructions with each bottle type.

Storage: Store dry powder below 30°C (86°F). Store constituted suspension between 5° to 30°C (41° to 86°F) and discard when full dosing is completed.

Medication Guide

Health Professional Information

{{section_name_patient}}

{{section_body_html_patient}}

Resources

Didn’t find what you were looking for? Contact us.

MI Digital Assistant

Chat online with Pfizer Medical Information regarding your inquiry on a Pfizer medicine.

Call 800-438-1985*

*Contact Medical Information. 8AM-9PM ET Monday to Friday; excluding holidays.

Medical Inquiry

Submit a medical question for Pfizer prescription products.

Report Adverse Event

Pfizer Safety

To report an adverse event related to the Pfizer-BioNTech COVID-19 Vaccine, and you are not part of a clinical trial* for this product, click the link below to submit your information:

Pfizer Safety Reporting Site

*If you are involved in a clinical trial for this product, adverse events should be reported to your coordinating study site.

If you cannot use the above website, or would like to report an adverse event related to a different Pfizer product, please call Pfizer Safety at (800) 438-1985.

FDA Medwatch

You may also contact the U.S. Food and Drug Administration (FDA) directly to report adverse events or product quality concerns either online at www.fda.gov/medwatch or call (800) 822-7967.